Skip to main content
SpringerLink
Log in

Pathology of Liver Transplantation

  • Reference work entry
  • First Online:
Contemporary Liver Transplantation

Part of the book series: Organ and Tissue Transplantation ((OTT))

  • 1577 Accesses

Abstract

Liver biopsy is an integral part of the clinical management of liver transplant patients. In most cases, it provides essential information for diagnosis, assessment of disease activity and extent, and further guidance in treatment. In this chapter, the liver pathology of the most common disease entities in the post-transplant setting are reviewed, including early complications, rejection, and recurrent disease. For pathologists, it is crucial to recognize the pattern of injury on histopathology, and communication with the clinical team is important to arrive at a definitive diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Agopian VG, Kaldas FM, Hong JC et al (2012) Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg 256:624–633

    Article  PubMed  Google Scholar 

  • Alabraba E, Nightingale P, Gunson B et al (2009) A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl 15:330–340

    Article  PubMed  Google Scholar 

  • Banff Working Group, Demetris AJ, Adeyi O et al (2006) Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 44:489–501

    Article  Google Scholar 

  • Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19:1409–1417

    Article  CAS  PubMed  Google Scholar 

  • Berardi S, Lodato F, Gramenzi A et al (2007) High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? Gut 56:237–242

    Article  CAS  PubMed  Google Scholar 

  • Berlakovich GA (2014) Challenges in transplantation for alcoholic liver disease. World J Gastroenterol 20:8033–8039

    Article  PubMed  PubMed Central  Google Scholar 

  • Briceño J, Ciria R, Pleguezuelo M et al (2009) Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Liver Transpl 15:37–48

    Article  PubMed  Google Scholar 

  • Campsen J, Zimmerman MA, Trotter JF et al (2008) Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course. Liver Transpl 14:181–185

    Article  PubMed  Google Scholar 

  • Carbone M, Neuberger JM (2014) Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol 60:210–223

    Article  CAS  PubMed  Google Scholar 

  • Charatcharoenwitthaya P, Lindor KD (2008) Recurrence of primary sclerosing cholangitis: what do we learn from several transplant centers? Liver Transpl 14:130–132

    Article  PubMed  Google Scholar 

  • Cholongitas E, Burroughs AK (2012) Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects. Autoimmun Highlights 3:113–118

    Article  CAS  Google Scholar 

  • Chu MJ, Dare AJ, Phillips AR et al (2015) Donor hepatic steatosis and outcome after liver transplantation: a systematic review. J Gastrointest Surg 19:1713–1724

    Article  PubMed  Google Scholar 

  • Contos MJ, Cales W, Sterling RK et al (2001) Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 7:363–373

    Article  CAS  PubMed  Google Scholar 

  • Davies SE, Portmann BC, O’Grady JG et al (1991) Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 13:150–157

    Article  CAS  PubMed  Google Scholar 

  • deLemos AS, Schmeltzer PA, Russo MW (2014) Recurrent hepatitis C after liver transplant. World J Gastroenterol 20:10668–10681

    Article  PubMed  PubMed Central  Google Scholar 

  • Demetris AJ (2009) Evolution of hepatitis C virus in liver allografts. Liver Transpl 15(Suppl 2):S35–S41

    Article  PubMed  Google Scholar 

  • Demetris AJ, Batts KP, Dhillon AP et al (1997) Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 25:658–663

    Article  Google Scholar 

  • Demetris AJ, Adams D, Bellamy C et al (2000) Update of the International Banff Schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel. Hepatology 31:792–799

    Article  CAS  PubMed  Google Scholar 

  • Demetris AJ, Ruppert K, Dvorchik I et al (2002) Real-time monitoring of acute liver-allograft rejection using Banff schema. Transplantation 74:1290–1296

    Article  CAS  PubMed  Google Scholar 

  • Dumortier J, Boillot O, Scoazec J (2014) Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future. World J Gastroenterol 20:11069–11079

    Article  PubMed  PubMed Central  Google Scholar 

  • Dumortier J, Dharancy S, Cannesson A et al (2015) Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication. Am J Gastroenterol 110:1160–1166

    Article  PubMed  Google Scholar 

  • Dureja P, Mellinger J, Agni R et al (2011) NAFLD recurrence in liver transplant recipients. Transplantation 91:684–689

    Article  PubMed  Google Scholar 

  • European Liver Transplant Registry. http://www.eltr.org/

  • Faisal N, Renner EL (2015) Recurrence of autoimmune liver diseases after liver transplantation. World J Hepatol 7:2896–2905

    Article  PubMed  PubMed Central  Google Scholar 

  • Feil MI, Agarwal K, Stanca C et al (2008) Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl 14:861–871

    Article  Google Scholar 

  • Firpi RJ, Abdelmalek MF, Soldevila-Pico C et al (2004) One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection. Liver Transpl 10:1240–1247

    Article  PubMed  Google Scholar 

  • Fishbein TM, Fiel MI, Emre S et al (1997) Use of livers with microvesicular fat safely expands the donor pool. Transplantation 64:248–251

    Article  CAS  PubMed  Google Scholar 

  • Fosby B, Karlsen TH, Melum E (2012) Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol 18:1–15

    Article  PubMed  PubMed Central  Google Scholar 

  • Gabrielli M, Moisan F, Vidal M et al (2012) Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study. Ann Hepatol 11:891–898

    PubMed  Google Scholar 

  • Gane EJ, Portmann BC, Naoumov NV et al (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334:815–820

    Article  CAS  PubMed  Google Scholar 

  • Ghaziani T, Sendi H, Shahraz S et al (2014) Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome. World J Gastroenterol 20:14142–14155

    Article  PubMed  PubMed Central  Google Scholar 

  • Guido M, Burra P (2011) De novo autoimmune hepatitis after liver transplantation. Semin Liver Dis 31:71–81

    Article  PubMed  Google Scholar 

  • Haberal M, Dalgic A (2004) New concepts in organ transplantation. Transplant Proc 36:1219–1224

    Article  CAS  PubMed  Google Scholar 

  • Harring TR, O’Mahony CA, Goss JA (2011) Extended donors in liver transplantation. Clin Liver Dis 15:879–900

    Article  PubMed  Google Scholar 

  • Iruzubieta P, Crespo J, Fábrega E (2013) Long-term survival after liver transplantation for alcoholic liver disease. World J Gastroenterol 19:9198–9208

    Article  PubMed  PubMed Central  Google Scholar 

  • Jaffe R (1998) Liver transplant pathology in pediatric metabolic disorders. Pediatr Dev Pathol 1:102–117

    Article  CAS  PubMed  Google Scholar 

  • Katz LH, Paul M, Guy DG et al (2010) Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis. Transpl Infect Dis 12:292–308

    Article  CAS  PubMed  Google Scholar 

  • Kerkar N, Yanni G (2015) ‘De novo’ and ‘recurrent’ autoimmune hepatitis after liver transplantation: a comprehensive review. J Autoimmun 66:17–24

    Article  PubMed  Google Scholar 

  • Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatol 41:1313–1321

    Google Scholar 

  • Klintmalm GB, Jennings LW, Davis GL (2010) Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl 16:431–439

    PubMed  Google Scholar 

  • Lau JY, Bain VG, Davies SE et al (1992) High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 102:956–962

    Article  CAS  PubMed  Google Scholar 

  • Leroy V, Dumortier J, Coilly A et al (2015) Efficacy of sofosbuvir and daclatasvir in patients with fibrosing cholestatic hepatitis C after liver transplantation. Clin Gastroenterol Hepatol 13:1993–2001

    Article  CAS  PubMed  Google Scholar 

  • Levitsky J, Fiel MI, Norvell JP et al (2012) Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology 142:1132.e1–1139.e1

    Article  Google Scholar 

  • Liberal R, Longhi MS, Grant CR et al (2012) Autoimmune hepatitis after liver transplantation. Clin Gastroenterol Hepatol 10:346–353

    Article  PubMed  Google Scholar 

  • Lo CM, Cheung ST, Lai CL et al (2001) Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis. Ann Surg 233:276–281

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Malik SM, deVera ME, Fontes P et al (2009) Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 9:782–793

    Article  CAS  PubMed  Google Scholar 

  • Martin P, DiMartini A, Feng S et al (2014) Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 59:1144–1165

    Article  PubMed  Google Scholar 

  • Mason AL, Wick M, White HM et al (1993) Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology 105:237–244

    Article  CAS  PubMed  Google Scholar 

  • McCormack L, Petrowsky H, Jochum W et al (2007) Use of severely steatotic grafts in liver transplantation: a matched case–control study. Ann Surg 246:940–946

    Article  PubMed  Google Scholar 

  • McElroy LM, Daud A, Davis AE et al (2014) A meta-analysis of complications following deceased donor liver transplant. Am J Surg 208:605–618

    Article  PubMed  PubMed Central  Google Scholar 

  • Merli M, Gentili F, Giusto M et al (2009) Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis? Dig Liver Dis 41:345–349

    Article  CAS  PubMed  Google Scholar 

  • Mutimer D, Dusheiko G, Barrett C et al (2000) Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up. Transplantation 70:809–815

    Article  CAS  PubMed  Google Scholar 

  • Neuberger J (2003) Liver transplantation for primary biliary cirrhosis. Autoimmun Rev 2:1–7

    Article  PubMed  Google Scholar 

  • Neumann UP, Berg T, Bahra M et al (2004) Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 41:830–836

    Article  CAS  PubMed  Google Scholar 

  • O’Grady JG, Smith HM, Davies SE et al (1992) Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 14:104–111

    Article  PubMed  Google Scholar 

  • Patel YA, Berg CL, Moylan CA (2016) Nonalcoholic fatty liver disease: key considerations before and after liver transplantation. Dig Dis Sci 61:1406–1416

    Article  CAS  PubMed  Google Scholar 

  • Patil DT, Yerian LM (2012) Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation. Liver Transpl 18:1147–1153

    Article  PubMed  Google Scholar 

  • Pawlak J, Grodzicki M, Leowska E et al (2003) Vascular complications after liver transplantation. Transplant Proc 35:2313–2315

    Article  CAS  PubMed  Google Scholar 

  • Perrillo RP, Wright T, Rakela J et al (2001) A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology 33:424–432

    Article  CAS  PubMed  Google Scholar 

  • Piardi T, Lhuaire M, Bruno O et al (2016) Vascular complications following liver transplantation: a literature review of advances in 2015. World J Hepatol 8:36–57

    Article  PubMed  PubMed Central  Google Scholar 

  • Prieto M, Berenguer M, Rayón JM et al (1999) High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 29:250–256

    Article  CAS  PubMed  Google Scholar 

  • Rockey DC, Caldwell SH, Goodman ZD et al (2009) Liver biopsy. Hepatology 49:1017–1044

    Article  PubMed  Google Scholar 

  • Saab S, Jimenez M, Bau S et al (2015) Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysis. Clin Transplant 29:813–819

    Article  CAS  PubMed  Google Scholar 

  • Sakashita H, Haga H, Ashihara E et al (2007) Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol 20:676–684

    Article  CAS  PubMed  Google Scholar 

  • Salomao M, Verna EC, Lefkowitch JH et al (2013) Histopathologic distinction between fibrosing cholestatic hepatitis C and biliary obstruction. Am J Surg Pathol 37:1837–1841

    Article  PubMed  Google Scholar 

  • Sanchez EQ, Levy MF, Goldstein RM et al (2003) The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation 76:1583–1588

    Article  PubMed  Google Scholar 

  • Saraf N, Fiel MI, Deboccardo G et al (2007) Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation. Liver Transpl 13:913–917

    Article  PubMed  Google Scholar 

  • Satapathy SK, Sclair S, Fiel MI et al (2011) Clinical characterization of patients developing histologically-proven fibrosing cholestatic hepatitis C post-liver transplantation. Hepatol Res 41:328–339

    Article  CAS  PubMed  Google Scholar 

  • Saxena R, Crawford JM, Navarro VJ et al (2002) Utilization of acidophil bodies in the diagnosis of recurrent hepatitis C infection after orthotopic liver transplantation. Mod Pathol 15:897–903

    Article  PubMed  Google Scholar 

  • Schön MR, Kollmar O, Akkoc N et al (1998) Cold ischemia affects sinusoidal endothelial cells while warm ischemia affects hepatocytes in liver transplantation. Transplant Proc 30:2318–2320

    Article  PubMed  Google Scholar 

  • Seo S, Maganti K, Khehra M et al (2007) De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transpl 13:844–847

    Article  PubMed  Google Scholar 

  • Spitzer AL, Lao OB, Dick AA et al (2010) The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl 16:874–884

    Article  PubMed  Google Scholar 

  • Sylvestre PB, Batts KP, Burgart LJ et al (2003) Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history. Liver Transpl 9:1086–1093

    Article  PubMed  Google Scholar 

  • Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: summary of recommendations developed by an international working party, supported by the World Congresses of Gastroenterology, Los Angeles, 1994. Am J Gastroenterol 89:S177–S181

    Google Scholar 

  • Tischendorf JJ, Hecker H, Krüger M et al (2007) Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 102:107–114

    Article  PubMed  Google Scholar 

  • Tripathi D, Neuberger J (2009) Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease. Semin Liver Dis 29:286–296

    Article  PubMed  Google Scholar 

  • Trivedi PJ, Hirschfield GM (2012) Review article: overlap syndromes and autoimmune liver disease. Aliment Pharmacol Ther 36:517–533

    Article  CAS  PubMed  Google Scholar 

  • Vallin M, Guillaud O, Boillot O et al (2014) Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis. Liver Transpl 20:1064–1071

    Article  PubMed  Google Scholar 

  • Verna EC, Abdelmessih R, Salomao MA et al (2013) Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis. Liver Transpl 19:78–88

    Article  PubMed  Google Scholar 

  • Wang HL, Anderson CD, Glasgow S et al (2011) Liver. In: Liapis H, Wang HL (eds) Pathology of solid organ transplantation, 1st edn. Springer, Berlin/Heidelberg

    Google Scholar 

  • Ward SC, Schiano TD, Thung SN et al (2009) Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case–control study showing poor outcome and predictive features in the liver explant. Liver Transpl 15:1826–1833

    Article  PubMed  Google Scholar 

  • Westerkamp AC, de Boer MT, van den Berg AP et al (2015) Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short. Transpl Int 28:319–329

    Article  CAS  PubMed  Google Scholar 

  • Wiesner RH, Sorrell M, Villamil F (2003) Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transpl 9:S1–S9

    Article  PubMed  Google Scholar 

  • Wojcicki M, Milkiewicz P, Silva M (2008) Biliary tract complications after liver transplantation: a review. Dig Surg 25:245–527

    Article  PubMed  Google Scholar 

  • Wu J, Ye S, Xu X et al (2011) Recipient outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis. PLoS One 6:e16521

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang D, Jiao Z, Han J et al (2014) Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience. Int J Clin Exp Pathol 7:4057–4066

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathology, Thomas Jefferson University Hospital, Philadelphia, PA, USA

    Wei Jiang

  2. Thomas Jefferson University Hospital, Philadelphia, PA, USA

    John L. Farber

Authors
  1. Wei Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John L. Farber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Wei Jiang or John L. Farber .

Editor information

Editors and Affiliations

  1. Nicoletti Family Professor of Transplant Surgery, Director, Jefferson Transplant Institute, Director, Division of Transplantation, Surgical Director, Kimmel Cancer Center – Jefferson Liver Tumor Center, Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA

    Cataldo Doria

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this entry

Cite this entry

Jiang, W., Farber, J.L. (2017). Pathology of Liver Transplantation. In: Doria, C. (eds) Contemporary Liver Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-07209-8_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-07209-8_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-07208-1

  • Online ISBN: 978-3-319-07209-8

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation